X

Select a search constraint:



ARROW® ErgoPack™

ArrowEVOLUTION with Chlorag+ard® technology

The only peripherally inserted central catheter (PICC) that provides broad-spectrum antimicrobial protection1

The application of Chlorag+ard® utilizes a proprietary process whereby chlorhexidine is chemically bonded to the catheter surface, providing a controlled release of the antimicrobial agent. Chlorag+ard® is designed to reduce colonization of pathogens responsible for causing central line–associated bloodstream infections (CLABSIs).

Chlorag+ard® technology complements your facility's efforts toward attaining and sustaining zero CLABSIs by protecting the catheter surfaces where pathogens attach.

Chlorag+ard® technology raises protection to a new standard

Meets the latest stringent regulatory requirements for antimicrobial devices and achieves a 4-log10 reduction, with only 1 in 10,000 surviving organisms.1

Comparison of log reduction in pathogens

Base-10 logarithmic system Reduction Surviving organisms Examples
1-log reduction 90% 1 in 10 NA
2-log reduction 99% 1 in 100 NA
3-log reduction 99.9% 1 in 1000 ChloraPrep®
4-log reduction 99.99% 1 in 10,000 Chlorag+ard® *

* Chlorag+ard® and ChloraPrep provide effective antimicrobial protection in different environments.

Proven protection, both inside and outside of the lumen

In vitro external efficacy of Chlorag+ard technology In vitro ixternal efficacy of Chlorag+ard technology

To learn more about the benefits of Chlorag+ard® technology, download the Chlorag+ard® Technology Information Sheet. (PDFPDF 400k)

MRSE = methicillin-resistant Staphylococcus epidermidis; VRE = vancomycin-resistant enterococci; MRSA = methicillin-resistant Staphylococcus aureus; MSSE = methicillin-sensitive Staphylococcus epidermidis; MSSA = methicillin-sensitive Staphylococcus aureus.